Prelude Capital Management’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,000
Closed -$48.8K 1292
2025
Q4
$48.8K Buy
17,000
+1,300
+8% +$3.6K ﹤0.01% 1236
2025
Q3
$63.7K Buy
+15,700
New +$62.7K 0.01% 1093
2024
Q2
Sell
-11,584
Closed -$93.5K 1276
2024
Q1
$93.5K Buy
+11,584
New +$102K ﹤0.01% 1208

Other funds holding DH

Prelude Capital Management's DH Position: Q1 2026 in Review

Prelude Capital Management sold out of Definitive Healthcare (DH) in Q1 2026, closing a stake of 17,000 shares — an estimated $48.8K sold.

Prelude Capital Management first reported a position in DH in Q1 2024 and held it in 3 quarters. The position peaked at $93.5K in Q1 2024. 119 funds tracked by Wall St. Rank hold DH as of Q1 2026.

  • Prelude Capital Management reported no remaining Definitive Healthcare position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 17,000 Definitive Healthcare shares in Q1 2026, an estimated $48.8K.
  • Prelude Capital Management first reported a position in Definitive Healthcare in Q1 2024 and held it in 3 quarters.
  • Prelude Capital Management's Definitive Healthcare position peaked at $93.5K in Q1 2024.
  • 119 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.